From Data to Decision: Standardization, Validation, and Regulatory Readiness of AI-Driven Analytical Chemistry Workflows

Artificial intelligence (AI) is fundamentally reshaping analytical chemistry by enabling automated data interpretation, intelligent method optimization, and increasingly autonomous analytical workflows across pharmaceutical quality control, environmental monitoring, and clinical diagnostics. Despite remarkable recent advances, widespread regulatory-ready deployment remains constrained by critical translational barriers, including insufficient external validation, inadequate model interpretability, and the absence of coherent lifecycle governance frameworks. This review critically evaluates the current landscape of AI-driven analytical chemistry with particular emphasis on hyphenated chromatographic platforms—especially reverse-phase high-performance liquid chromatography (RP-HPLC) and its hyphenated configurations—as primary technological substrates for AI integration. The roles of Explainable AI (XAI), Uncertainty Quantification (UQ), FAIR data governance, and continuous lifecycle validation are assessed against key international regulatory frameworks, including ICH Q2(R2), ICH Q14, GAMP 5, FDA Computer Software Assurance (CSA) guidance, Good Machine Learning Practice (GMLP), and EMA AI perspectives. Two translational gaps are defined and critically examined: the Validation Gap (disconnect between high internal model performance and limited external reproducibility evidence) and the Discrepancy Gap (deterioration of model performance under real-world deployment conditions due to domain shift and instrument heterogeneity). The review further presents a milestone timeline for RP-HPLC hyphenation, a critical comparative analysis of hyphenated techniques including LC–MS/MS, LC–NMR, LC–ICP-MS, and LC–HRMS, and a new comprehensive table of reported AI/ML applications in chromatographic method development. Key recommendations are provided for bridging the path from proof-of-concept AI tools to trustworthy, decision-ready analytical ecosystems.

Authors

Institutions

Publication Details

Journal
Critical Reviews in Analytical Chemistry
Published
2026-06-29
DOI
https://doi.org/10.1080/10408347.2026.2694610
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From Data to Decision: Standardization, Validation, and Regulatory Readiness of AI-Driven Analytical Chemistry Workflows

Taibah Aldakhil, Samah Abo El Abass, Abdulmalik S. A. Altamimi, Pintu Prajapati
Critical Reviews in Analytical Chemistry
Computational Drug Discovery Methods
article

From Data to Decision: Standardization, Validation, and Regulatory Readiness of AI-Driven Analytical Chemistry Workflows

Taibah Aldakhil, Samah Abo El Abass, Abdulmalik S. A. Altamimi, Pintu Prajapati
article en

Abstract

Artificial intelligence (AI) is fundamentally reshaping analytical chemistry by enabling automated data interpretation, intelligent method optimization, and increasingly autonomous analytical workflows across pharmaceutical quality control, environmental monitoring, and clinical diagnostics. Despite remarkable recent advances, widespread regulatory-ready deployment remains constrained by critical translational barriers, including insufficient external validation, inadequate model interpretability, and the absence of coherent lifecycle governance frameworks. This review critically evaluates the current landscape of AI-driven analytical chemistry with particular emphasis on hyphenated chromatographic platforms—especially reverse-phase high-performance liquid chromatography (RP-HPLC) and its hyphenated configurations—as primary technological substrates for AI integration. The roles of Explainable AI (XAI), Uncertainty Quantification (UQ), FAIR data governance, and continuous lifecycle validation are assessed against key international regulatory frameworks, including ICH Q2(R2), ICH Q14, GAMP 5, FDA Computer Software Assurance (CSA) guidance, Good Machine Learning Practice (GMLP), and EMA AI perspectives. Two translational gaps are defined and critically examined: the Validation Gap (disconnect between high internal model performance and limited external reproducibility evidence) and the Discrepancy Gap (deterioration of model performance under real-world deployment conditions due to domain shift and instrument heterogeneity). The review further presents a milestone timeline for RP-HPLC hyphenation, a critical comparative analysis of hyphenated techniques including LC–MS/MS, LC–NMR, LC–ICP-MS, and LC–HRMS, and a new comprehensive table of reported AI/ML applications in chromatographic method development. Key recommendations are provided for bridging the path from proof-of-concept AI tools to trustworthy, decision-ready analytical ecosystems.

Critical Reviews in Analytical Chemistry
Uka Tarsadia University (IN), Prince Sattam Bin Abdulaziz University (SA)
Openalex Percentile: Top 6%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.